Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07442448) titled 'Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Cathay General Hospital
Condition:
Heart Failure and Preserved Ejection Fraction
Heart Failure
Heart Failure and Mildly Reduced Ejection Fraction
Intervention:
Drug: Finerenone
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: April 2026
Target Sample Size: 40
Countries ...